Collegium_rgb_small.jpg
Source: Collegium Pharmaceutical, Inc.

Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences in December:

  • The Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3rd in New York City. Management will present at 2:30 p.m. ET and will also participate in investor meetings.  
     
  • The Jefferies Biopharma Summit on Thursday, December 12th in Denver. Management will participate in investor meetings.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.


Alex Dasalla
adasalla@collegiumpharma.com